Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 18, 2023 08:45 ET | Source: Gabelli Funds

Gabelli Funds Presents Talkin’ ‘Bout 3 Generations of Dinsmore Convertible Management

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6dbbac6e-7a71-478e-910e-5ab37f8f1e2c RYE, N.Y., July 18, 2023 (GLOBE NEWSWIRE) --...
July 12, 2023 07:00 ET | Source: Psyence Group Inc.

Psyence Group Corporate Update

Highlights: Drug development, Phase IIb clinical trial advanced planning underway in AustraliaPsyence granted worldwide licensing agreement to commercialize Filament’s PEX010 (25 mg) in...
June 02, 2023 09:05 ET | Source: Gabelli Funds

UPDATE - Gabelli Funds Presents Back to the Future with Closed-End Funds

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d5522b78-cf88-4830-b150-38763f653351 RYE, N.Y., June 02, 2023 (GLOBE NEWSWIRE) --...
June 01, 2023 09:05 ET | Source: Gabelli Funds

Gabelli Funds Presents Back to the Future with Closed-End Funds

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d5522b78-cf88-4830-b150-38763f653351. RYE, N.Y., June 01, 2023 (GLOBE NEWSWIRE) -- Gabelli...
May 11, 2023 16:05 ET | Source: Kinnate Biopharma

Kinnate Biopharma Inc. Reports First Quarter 2023 Financial Results and Recent Corporate Updates

Presented positive monotherapy dose escalation data for exarafenib, an investigational pan-RAF inhibitor, at the 2023 AACR Annual Meeting Provided update on ongoing exarafenib monotherapy dose...
May 11, 2023 10:00 ET | Source: REPORTSINSIGHTS CONSULTING PVT LTD

Fermentation Chemicals Market Growing Rapid Pace to Attain US$105.20 Billion by 2030

New York, May 11, 2023 (GLOBE NEWSWIRE) -- As per the research report Global Fermentation chemicals Market published by Reports Insights, the market amounted to USD 65.00 Billion in 2022 and is...
May 10, 2023 16:15 ET | Source: Tempest Therapeutics

Tempest Reports First Quarter 2023 Financial Results and Provides Business Update

BRISBANE, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-classi therapeutics that combine both targeted and...
May 09, 2023 16:05 ET | Source: GAMCO Investors, Inc.

GAMCO Investors, Inc. (“GAMI”) Reports Results for the First Quarter 2023

March 31, 2023 AUM of $30.7 billion vs. $29.3 billion at December 31, 2022 Equity AUM was $27.1 billion and U.S. Treasury Money Market Fund was $3.6 billion at March 31, 2023 Revenues of $59.9 million...
May 09, 2023 16:05 ET | Source: Design Therapeutics, Inc.

Design Therapeutics Provides Pipeline Updates and Reports First Quarter 2023 Financial Results

Initial Data from Phase 1 Multiple-Ascending Dose Trial of DT-216 for Friedreich Ataxia Expected in the Third Quarter of 2023 Progress Across GeneTAC™ Small Molecule Pipeline with IND Submissions...
May 09, 2023 08:00 ET | Source: Vaxxinity, Inc.

Vaxxinity Reports First Quarter 2023 Financial Results and Provides Corporate Update

CAPE CANAVERAL, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported...